EUVIMEDEUVIMED entdecken
Crossref

Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance

Lianlian Wu, Judith Honing, Anjui Wu, Sonia S Kupfer, Tanya M Bisseling, Jolanda M van Dieren, W Keith Tan, Colin Y C Lee, Andreas V Hadjinicolaou, Yuan Huang, Juan de la Revilla Negro, Mohmmed Tauseef Sharip und 12 weitere

Endoscopy · 01.10.2025 · 57 (10) · 1118-1127

DOI: 10.1055/a-2634-7895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.10.2025. Verfasst von Lianlian Wu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Early Cancer Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom of Great Britain and Northern Ireland. Hauptthemen laut MEDLINE: Carcinoma, Signet Ring Cell, Stomach Neoplasms, Decision Trees, Gastroscopy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Addenbrookes Charitable Trust, Medical Research Council, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prophylactic total gastrectomy is the definitive treatment for hereditary diffuse gastric cancer syndrome (HDGC). Endoscopic surveillance informs the requirement for and optimal timing of surgery. However, endoscopic recognition of early signet ring cell carcinoma (SRCC) remains challenging. We developed an endoscopic framework to optimize SRCC assessment during HDGC surveillance. We retrospectively analyzed data from 147 individuals with HDGC undergoing endoscopic surveillance to evaluate the diagnostic accuracy of the endoscopic Cambridge criteria. We used machine learning to develop a clinical decision tree (cDT) to guide the application of the Cambridge criteria. We then prospectively validated the cDT in 66 CDH1 pathogenic-variant carriers. The interobserver agreement and diagnostic accuracy of the Cambridge criteria and cDT were assessed through a multi-reader multi-case study. Retrospective analysis of 537 endoscopies showed that the Cambridge criteria achieved 82.8% (48/58) sensitivity and 78.2% (140/179) specificity for SRCC diagnosis. The presence and number of neoplastic pale areas were independent predictors of higher cancer burden in HDGC individuals. In the prospective study, cDT had 77.8% (21/27) sensitivity and 90.7% (49/54) specificity, and improved performance of both experts and non-experts. We developed and validated a practical endoscopic framework for enhancing SRCC assessment during HDGC endoscopic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Signet Ring CellStomach NeoplasmsDecision TreesGastroscopyNeoplastic Syndromes, HereditaryHumansMaleFemaleMiddle AgedRetrospective StudiesAdultProspective StudiesCadherinsSensitivity and SpecificityMachine LearningAgedEarly Detection of CancerAntigens, CD

Substanzen

CDH1 protein, humanCadherinsAntigens, CD

Autor:innen und Institutionen

  • Early Cancer Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom of Great Britain and Northern Ireland.
  • Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • Department of Gastroenterology and Hepatology, Rotterdam Medical Centre, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • Section of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, United States.
  • Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.

Förderung

  • Addenbrookes Charitable Trust
  • Medical Research Council
  • Cancer Research UK
  • UK Medical Research Council
  • Cancer Research UK Cambridge
  • Program of the Chinese Scholarship Council
  • CRUK grant
  • Gates Cambridge Trust

Zitieren

APA

Wu, L., Honing, J., Wu, A., Kupfer, S. S., Bisseling, T. M., van Dieren, J. M., Tan, W. K., Lee, C. Y. C., Hadjinicolaou, A. V., Huang, Y., Negro, J. R., Sharip, M. T., Elias, J., Lim, H. J., Karthik, N., Markert, G., Prew, W., O'Donovan, M., Tischkowitz, M., …, & di Pietro, M. (2025). Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance. Endoscopy, 57(10), 1118-1127. https://doi.org/10.1055/a-2634-7895

Vancouver

Wu L, Honing J, Wu A, Kupfer SS, Bisseling TM, van Dieren JM, et al. Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance. Endoscopy. 2025;57(10):1118-1127. doi:10.1055/a-2634-7895

BibTeX
@article{Wu2025,
  author = {Wu, Lianlian and Honing, Judith and Wu, Anjui and Kupfer, Sonia S and Bisseling, Tanya M and van Dieren, Jolanda M and Tan, W Keith and Lee, Colin Y C and Hadjinicolaou, Andreas V and Huang, Yuan and Negro, Juan de la Revilla and Sharip, Mohmmed Tauseef and Elias, Joshua and Lim, Hui Jun and Karthik, Nandini and Markert, Greta and Prew, William and O'Donovan, Maria and Tischkowitz, Marc and Sujendran, Vijayendran and O'Neill, J Robert and Markowetz, Florian and Fitzgerald, Rebecca C and di Pietro, Massimiliano},
  title = {Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {10},
  pages = {1118--1127},
  doi = {10.1055/a-2634-7895}
}
Kostenlos starten →